Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Enterprise ValueMarket Capitalization

RAPT Therapeutics (RAPT) Net Margin: 2020-2022

Historic Net Margin for Therapeutics (RAPT) over the last 2 years, with Jun 2022 value amounting to -2,134.20%.

  • Therapeutics' Net Margin fell 28034.00% to -2,134.20% in Q2 2022 from the same period last year, while for Jun 2022 it was -2,347.37%, marking a year-over-year decrease of 112831.00%. This contributed to the annual value of -5,618.53% for FY2022, which is 380358.00% down from last year.
  • Latest data reveals that Therapeutics reported Net Margin of -2,134.20% as of Q2 2022, which was up 34.16% from -3,241.34% recorded in Q1 2022.
  • Over the past 5 years, Therapeutics' Net Margin peaked at -957.53% during Q3 2020, and registered a low of -3,241.34% during Q1 2022.
  • Over the past 3 years, Therapeutics' median Net Margin value was -1,629.55% (recorded in 2021), while the average stood at -1,719.40%.
  • Its Net Margin has fluctuated over the past 5 years, first spiked by 5,385bps in 2021, then slumped by 188,995bps in 2022.
  • Therapeutics' Net Margin (Quarterly) stood at -978.11% in 2020, then crashed by 139,345bps to -2,371.56% in 2021, then tumbled by 28,034bps to -2,134.20% in 2022.
  • Its Net Margin was -2,134.20% in Q2 2022, compared to -3,241.34% in Q1 2022 and -2,371.56% in Q4 2021.